^ Diagnostic and treatment cost are estimates based on mapping of private hospital costs with cancer diagnostic & treatment pathways per stage of detection
*Source: https://www.hindustantimes.com/india-news/one-in-10-indians-will-develop-cancer-during-their-lifetime-who/story-NcNQhPTS01YWI9Qovfcy5J.html
*Source: https://www.hindustantimes.com/lifestyle/health/cancer-risk-factors-here-s-why-indians-are-at-a-higher-risk-of-the-disease-101675603191553.html
EDIM (Epitope Detected in Monocytes) Technology detects elevated levels of enzyme tumor biomarkers (Apo10 & TKTL-1) in macrophages. It leverages on our innate immune system, wherein macrophages do a biological biopsy and engulf universal enzyme tumor biomarkers (Apo10 & TKTL-1) when they phagocytose degenerated tumor cells.
The human immune system is first to recognize the progression of disease, even before the onset of symptoms. EDIM® (Epitope Detection in Monocytes/Macrophages) technology makes the information contained in the human immune system visible for detection of cancer. Higher than normal levels of Apo10 (DNaseX) & TKTL1 detected in immune cells (macrophages) of screened individuals gives an indication of potential cancer and pre-cancer lesions in early and symptomless stages for healthy individuals.
© 2023. All rights reserved